- Home
- WRB vs BNTX Comparison
WRB vs BNTX Comparison
Compare WRB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WRB | BNTX |
|---|---|---|
| Founded | 1967 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.5B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | WRB | BNTX |
|---|---|---|
| Price | $70.03 | $98.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 11 |
| Target Price | $71.64 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 3.5M | 1.2M |
| Earning Date | 01-26-2026 | 11-03-2025 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | ★ 22.08 | N/A |
| EPS | ★ 4.76 | N/A |
| Revenue | ★ $14,654,011,000.00 | $3,698,814,972.00 |
| Revenue This Year | $9.29 | $2.03 |
| Revenue Next Year | $5.48 | N/A |
| P/E Ratio | $14.85 | ★ N/A |
| Revenue Growth | ★ 11.08 | 3.70 |
| 52 Week Low | $55.97 | $81.20 |
| 52 Week High | $78.96 | $129.27 |
Technical Indicators
Market Signals| Indicator | WRB | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 58.24 |
| Support Level | $68.70 | $95.85 |
| Resistance Level | $71.08 | $95.71 |
| Average True Range (ATR) | 1.07 | 1.79 |
| MACD | 0.26 | 0.80 |
| Stochastic Oscillator | 61.26 | 87.94 |
Price Performance
Historical ComparisonAbout WRB W.R. Berkley Corporation
W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.